The publication "Cancer Control 2024: Cancer Care in Emerging Health Systems" was recently released by Global Health Dynamics. The GCR is grateful for the opportunity to contribute to this important publication. To access the PDF for download, click the link below.
RESPONSES TO CANCER CONTROL SURVEY 2024
An international healthcare audience shared their responses to a cancer control survey. Darien Laird, GCR Executive Director provided the following information.
“When global events occur, cancer patients are among the most vulnerable, even in countries prioritizing cancer control. Healthcare systems may deteriorate, especially in underserved regions, compelling patients to seek treatment across borders. Ongoing conflicts in the Middle East, Ukraine, Syria, and parts of Africa exacerbate this issue. Without effective planning, resilient healthcare systems, robust radiotherapy infrastructure, and international cooperation, treatable cancers may remain uncured, and patient care will be compromised.”
ESSENTIAL STANDARDS FOR IMPLEMENTING QUALITY RADIOTHERAPY GLOBALLY
In collaboration with Lisa Stevens from the IAEA, Pat Price, GCR Chair of the board, Darien Laird, GCR Executive Director, Katie Wakeham, NHS Clinical Oncology Consultant at Imperial College Healthcare NHS Trust and GCR Radiotherapy Essential Standards Chair, GCR published the Radiotherapy Essential Standards Article.
Authors (L-R): Pat Price, Darien Laird,
Katie Wakeham, Lisa Stevens
“It is clear there is currently a lack of access to quality radiotherapy around the world, but the radiotherapy community sees this as an opportunity to come together as a united voice. Improving access to radiotherapy will not only impact effective cancer care, but it is an opportunity for improving patient outcomes now and in the future.”
Learn more about the GCR RT Essential Standards:
REPORT OF THE LONDON GLOBAL CANCER WEEK ROUND TABLE DISCUSSION
Pat Price, GCR Chair of the board, participated in a round table discussion at London Global Cancer Week last year, and the outcome of that discussion was presented here.
“To prevent or reduce future cancer incidence, the groundwork needs to have been laid decades in advance, offering no immediate reputational benefit or political advantage to government actors. If cancer cannot be prevented, cancer is best treated when it’s at an early stage, and so speed of diagnosis and treatment is key to saving lives.”
Join the GCR at London Global Cancer Week 2024 for the GCR sessions:
留言